Canagliflozin will receive new boxed warning about amputation risks
12 Jun, 2017 | 19:51h | UTCCanagliflozin will receive new boxed warning about amputation risks – ACP Internist (free)
FDA Drug Safety Communication: FDA confirms increased risk of leg and foot amputations with the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) (free)